A Medical Device to Treat Wide-Neck Brain Aneurysms — TORNADO-US

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Ruptured Cerebral Aneurysm Clinical Trial

Official title:
Treatment of Ruptured Wide-Neck Aneurysms With Nautilus Device Assisted Occlusion

Status Recruiting

Clinical Trial Summary

The study aims to evaluate the safety and probable benefit of a medical device to treat wide-neck ruptured brain aneurysms.

Patients with ruptured brain aneurysms will be treated with the Nautilus, then will be followed up for one year. ;

See also
Status	Clinical Trial	Phase
Completed	`NCT01893190` - Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage	Phase 1/Phase 2
Not yet recruiting	`NCT04548856` - Microsurgical Clipping and Endovascular Embolization Comparative Prospective Randomized Trial	N/A
Active, not recruiting	`NCT01593267` - Barrow Ruptured Aneurysm Trial	N/A
Completed	`NCT05268445` - Chemical and Mechanical Angioplasty for Vasospasm (SAVEBRAIN)	N/A
Recruiting	`NCT03936647` - The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices	N/A
Completed	`NCT03778723` - Effect of Propofol Midazolam on Cerebral Oxygenation and Metabolism During Clipping of Ruptured Cerebral Aneurysm	N/A